AGP Executive Report
Last update: 11 hours agoBiotech: New Haven-based Invivyd has more than doubled its headquarters as it develops a broader COVID-19 prevention drug and treatments for other infections. Growth depends on successful drug development and replacing its current product. Coverage Costs: Connecticut employers are turning to individual coverage reimbursement plans to manage rising insurance costs. A new state tax credit may spur adoption, but workers must choose their own plans and premiums could offset savings. Access to Care: Membership-based practices offer longer visits and easier doctor access for a fee, but could further limit options where primary-care doctors are already scarce. Connecticut children with Medicaid also face long waits for eye care, while Manchester Memorial nurses warn short staffing puts patients at risk. Food Safety: A raw cheddar recall includes cheese sold in Connecticut after testing found two E. coli strains. No illnesses have been reported; check packages for the 7/22/27 best-by date. Hospital Policy: The Trump administration is encouraging states to loosen hospital approval laws to score higher for rural-health funding, a push that could affect where facilities and services expand.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
